farmatic biotech energy ag
farmatic biot. energy ag english
farmatic biotech energy ag achieves increase in turnover in the first quarter
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Nortorf, May 31, 2002.farmatic biotech energy ag (SIN 605192) achieved earnings
from sales amounting to 6.5 million euros in the first quarter of 2002 (compared
with 5.8 million euros for the same quarter in the previous year). The bio-
power plant technology sector contributed 5.5 million euros (compared with 5.5
million for the same quarter in the previous year) to overall turnover. The
remaining earnings came from the sewage treatment technology sector. The
operational results (EBIT) amounted to-2.7 million euros (compared with 0.5
million euros for the same quarter in the previous year).
The construction of biogas plants and biological sewage waste water treatment
plants was adversely affected in the first quarter of the year by poor weather
conditions. The biggest proportion of sales for farmatic ag regularly occurs in
the second half of the year.
Explanations and information on the ad-hoc statement
Based in Nortorf, Germany, farmatic biotech energy ag is one of the leading
companies for the industrial conversion of biomass into biogas for the
production of regenerative energy. In its Bio-Power Plant Technology division
farmatic is engaged in the development, planning and construction of mid-sized
and large industrially-operated biogas power plants. These power plants are
either operated by farmatic itself or in cooperation with other companies. The
companys Sewage Treatment Technology division comprises the development,
planning and construction of biological waste water purification plants.
farmatic has been listed on the Neuer Markt segment of the German stock exchange
since April 9, 2001 (SIN 605192).
Please contact Ms. Margitta Kley (Corporate Communications) if you require
further details. Telephone: +49 (4392) 9177-128, Fax: +49 (4392) 9177-297, E-
mail: ir@farmatic.com
end of ad-hoc-announcement (c)DGAP 31.05.2002
——————————————————————————–
WKN: 605192 ; ISIN: DE0006051923; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart;
310757 Mai 02
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found